Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

May 7, 2020 Leave a comment 1,619 Views

Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: genomic cancer testing

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

TileDB launches cross-language access to single-cell data

Researchers have developed an instrument-free single-cell RNA sequencing using a reversible hydrogel for cell-specific barcoding

Transcriptomic analysis of yeast paves way to more efficient production of 2G ethanol

Upcoming Webinar – RNA-Seq: Enhancing Single-Cell Data & Cell Recovery Rates for Complex Tissue Samples

A dual-purpose polymerase engineered for direct sequencing of pseudouridine and queuosine RNA modifications

RNA sequencing data from The Cancer Genome Atlas reveals a potential new target for head and neck cancer immunotherapy

Benchmarking integration of single-cell differential expression